-
公开(公告)号：US20170151343A1
公开(公告)日：2017-06-01
申请号：US15363715
申请日：2016-11-29
IPC分类号： A61K47/48 , A61K38/07 , A61K31/5517 , C07K16/30
CPC分类号： A61K31/5517 , A61K38/07 , A61K39/3955 , A61K47/6803 , A61K47/6849 , A61K47/6851 , A61K47/6889 , A61K2039/505 , C07K16/28 , C07K16/2818 , C07K16/30 , C07K2317/24 , C07K2317/73 , C07K2317/77 , C07K2317/92 , A61K2300/00
摘要： The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
-
公开(公告)号：US20190105328A1
公开(公告)日：2019-04-11
申请号：US16219450
申请日：2018-12-13
IPC分类号： A61K31/5517 , A61K47/68 , C07K16/28 , A61K39/395 , A61K38/07 , C07K16/30 , A61K39/00
摘要： The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
-
公开(公告)号：US20170151344A1
公开(公告)日：2017-06-01
申请号：US15363786
申请日：2016-11-29
IPC分类号： A61K47/48 , A61K38/07 , A61K31/5517 , C07K16/30
CPC分类号： A61K31/5517 , A61K38/07 , A61K47/6803 , A61K47/6849 , A61K47/6851 , A61K47/6889 , C07K16/28 , C07K16/30 , C07K2317/24 , C07K2317/77 , C07K2317/92
摘要： The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
-
公开(公告)号：US20190105329A1
公开(公告)日：2019-04-11
申请号：US16219547
申请日：2018-12-13
IPC分类号： A61K31/5517 , A61K47/68 , C07K16/28 , A61K39/395 , A61K38/07 , C07K16/30 , A61K39/00
摘要： The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
-
公开(公告)号：US20190099431A1
公开(公告)日：2019-04-04
申请号：US16216795
申请日：2018-12-11
IPC分类号： A61K31/5517 , A61K47/68 , A61K38/07 , C07K16/30 , C07K16/28
摘要： The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
-
公开(公告)号：US20180222979A1
公开(公告)日：2018-08-09
申请号：US15819153
申请日：2017-11-21
发明人： Kurt C. GISH , Han K. Kim , Louie Naumovski
CPC分类号： C07K16/2806 , A61K31/454 , A61K31/573 , A61K31/69 , A61K31/704 , A61K39/395 , A61K45/06 , A61K47/6803 , A61K47/6813 , A61K47/6851 , A61K47/6867 , A61K2039/505 , A61K2300/00 , C07K16/2803 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/73 , C07K2317/92
摘要： The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.023 秒)
